ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 1095

A20(Tnfaip3) in Keratinocytes Restricts an Early Antiviral Gene Program Associated with Psoriatic Skin and Joint Disease

Bahram Razani1, Jared Liu1, Ryan Tobias1, Sugandh Kumar1, Zhi-Ming Huang1, Wilson Liao2, Barbara Malynn3 and Averil Ma3, 1Dept. of Dermatology, UCSF, San Francisco, 2Dept. of Dermatology, San Francisco, 3Division of Gastroenterology, UCSF, San Francisco

Meeting: ACR Convergence 2022

Keywords: Animal Model, immunology, Inflammation, Psoriatic arthritis, skin

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Abstracts: Spondyloarthritis Including PsA – Basic Science

Session Type: Abstract Session

Session Time: 10:30AM-11:30AM

Background/Purpose: A20 (Tnfaip3) levels are reduced in psoriatic plaques and polymorphisms in the TNFAIP3 gene locus are associated with increased risk for both psoriasis and psoriatic arthritis. A20 is a ubiquitin binding and editing molecule that acts as a key negative regulator of inflammatory signaling. Our prior work using knock-in mice showed that non-enzymatic A20 binding to linear ubiquitin restricted psoriatic skin and joint disease. The earliest inflammatory changes in these mice surrounded the epidermis of the distal digits. Therefore, we aimed to determine if keratinocyte A20 was critical for restricting psoriatic skin and joint disease.

Methods: We generated mice with tamoxifen inducible conditional deletion of A20 in keratinocytes (A20eKO mice) and performed detailed immunological and transcriptomic analysis of tissues and primary keratinocytes in adult mice. We also generated multiple compound mutant mice with cytokines known to play a role in psoriatic arthritis.

Results: A20eKO mice developed progressive psoriatic skin and joint disease of their distal digits with complete penetrance. Skin and joint pathology was dependent on TNF, IL17A, IL23, and T-cells, reflecting factors known to play a role in human psoriatic disease. The earliest in vivo transcriptomic changes following A20 deletion in keratinocytes demonstrated a profound antiviral gene program. Intriguingly, deletion of A20 in primary keratinocytes in vitro resulted in spontaneous activation of antiviral genes, dependent the presence of Sting (Tmem173).

Conclusion: A20 in keratinocytes restricts not only psoriatic skin disease, but also psoriatic joint disease, suggesting an important role for epidermal immune homeostasis in preventing arthritis. Skin and joint pathology is dependent on TNF, IL17A, IL23, and T-cells, demonstrating the importance of epidermal A20 in restricting psoriatic cytokine and cellular networks. Intriguingly, the earliest transcriptomic changes following epidermal A20 loss in vivo is an antiviral gene program. This is reflected by primary keratinocytes in culture, suggesting a cell autonomous role for A20 in restricting antiviral genes. Furthermore, spontaneous induction of antiviral genes in primary keratinocytes in vitro was Sting (Tmem173) dependent. Given the known presence of antiviral genes in human psoriatic plaques, these studies raise the possibility that A20 prevents psoriatic skin and joint pathology in part by restricting a Sting-dependent antiviral gene program in keratinocytes.


Disclosures: B. Razani, None; J. Liu, Novartis, Janssen, TrexBio, Amgen; R. Tobias, None; S. Kumar, None; Z. Huang, None; W. Liao, AbbVie/Abbott, Janssen, Novartis, Pfizer, TRex Bio, Regeneron, Leo Pharma; B. Malynn, None; A. Ma, None.

To cite this abstract in AMA style:

Razani B, Liu J, Tobias R, Kumar S, Huang Z, Liao W, Malynn B, Ma A. A20(Tnfaip3) in Keratinocytes Restricts an Early Antiviral Gene Program Associated with Psoriatic Skin and Joint Disease [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/a20tnfaip3-in-keratinocytes-restricts-an-early-antiviral-gene-program-associated-with-psoriatic-skin-and-joint-disease/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a20tnfaip3-in-keratinocytes-restricts-an-early-antiviral-gene-program-associated-with-psoriatic-skin-and-joint-disease/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology